Stay updated with breaking news from External Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
RALEIGH, N.C., Jan. 31, 2022 /PRNewswire/ -- Immorna Biotherapeutics, Inc, an immune-oncology drug and viral vaccine development company with both...
/PRNewswire/ -- Immorna Biotherapeutics, Inc, an immune-oncology drug and viral vaccine development company with both proprietary self-replicating mRNA and...
/PRNewswire/ -- Immorna Biotherapeutics, Inc, an immune-oncology drug and viral vaccine development company with both proprietary self-replicating mRNA and...
Trading updates paint a grim picture of the consequence of lockdowns and poor consumer sentiment.
TymeBank International has received $180m from Tencent and the CDC Group to complete its Series B capital raise, which is intended to enhance the growing presence of TymeBank in South Africa, with GOTyme, another branch in the Philippines. TymeBank International has received $180m from Tencent...